LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Mar 26, 2024
Distillery Therapeutics
Targeting MMP8 for depression
Read More
BioCentury
|
Aug 10, 2023
Distillery Therapeutics
RNF41 gene therapy for chronic liver disease
Read More
BioCentury
|
Jan 7, 2022
Distillery Therapeutics
C1QTNF3 identified as target in tendinopathy
Read More
BioCentury
|
Oct 20, 2020
Deals
Oct. 19 Quick Takes: Genesis, Genentech in AI drug discovery deal; plus Endo-BioSpecifics, Gemini, Catalyst-Jacobus, ONK, Venclexta
Genesis and Genentech collaborate to identify drug candidates using AIStanford spinout and AI platform company Genesis Therapeutics Inc. entered into a collaboration agreement with the
Read More
BioCentury
|
Jul 22, 2020
Management Tracks
Meeker expands role at Rhythm; plus Biogen, Kronos, Citryll, Akcea, ImmunoGen, Circle, Antares and more
Read More
BioCentury
|
Jul 10, 2020
Finance
How buysiders are sizing up commercial launches during the pandemic
Buysiders defining new rules for analyzing product launches in the world of virtual sales
Read More
BioCentury
|
May 14, 2020
Management Tracks
Jakob Dupont steps down as CMO of Gossamer; plus Ascendis, Seer, Jazz, Dragonfly and more
Read More
BioCentury
|
Apr 14, 2020
Management Tracks
Kelly joins CytoDyn as CMO amid COVID-19 trials; plus Antengene, Genetron, Bolt, BioSpecifics, CMAB and more
Read More
BioCentury
|
Oct 10, 2019
Company News
Management tracks: Galderma taps new leadership from Shire; plus iOmx, BioSpecifics, Poseida, Kedalion, GenSight, Lyra, Verrica and Mizuho
Read More
BioCentury
|
Jun 20, 2018
Distillery Techniques
Drug platforms
Read More
Items per page:
10
1 - 10 of 262